Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly
Open accessAbstract
Apolipoprotein B (apoB) and microsomal triglyceride transfer protein (MTP) are necessary for lipoprotein assembly. ApoB consists of five structural domains, betaalpha(1)-beta(1)-alpha(2)-beta(2)-alpha(3). We propose that MTP contains three structural motifs (N-terminal beta-barrel, central alpha-helix, and C-terminal lipid cavity) and three functional domains (lipid transfer, membrane associating, and apoB binding). MTP's lipid transfer activity is required for the assembly of lipoproteins. This activity renders nascent apoB secretion-competent and may be involved in the import of triglycerides into the lumen of endoplasmic reticulum. In addition, MTP binds to apoB with high affinity involving ionic interactions. MTP interacts at multiple sites in the N-terminal betaalpha(1) structural domain of apoB. A novel antagonist that inhibits apoB-MTP binding decreases apoB secretion. Furthermore, site-directed mutagenesis and deletion analyses that inhibit apoB-MTP binding decrease apoB secretion. Lipids modulate protein-protein interactions between apoB and MTP. Lipids associated with MTP increase apoB-MTP binding whereas lipids associated with apoB decrease this binding. Thus, specific antagonist, site-directed mutagenesis, deletion analyses, and modulation studies support the notion that apoB-MTP binding plays a role in lipoprotein biogenesis. However, specific steps in lipoprotein assembly that require apoB-MTP binding have not been identified. ApoB-MTP binding may be important for the prevention of degradation and lipidation of nascent apoB.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The intracellular lipidation mechanism of ApoE is distinct from the mechanism involved in the biosynthesis of ApoB-containing LDL particles.
“indicating that the intracellular lipidation mechanism of ApoE is distinct from its more well-studied counterpart that is involved in the biosynthesis of ApoB-containing LDL particles.41”
From ApoE is Secreted as a Lipid Nanoparticle by Mammalian Cells: Implications for Alzheimer’s Disease Pathogenesis (2025) · cites this paper as [41]
The section ‘Importance of apoB-MTP binding in lipoprotein assembly’ (page unavailable) describes MTP-assisted lipidation of nascent apoB. The paper does not establish how ApoE is lipidated or compare its mechanism with apoB’s, so the claimed distinction is unsupported. (LLM, conf=0.84)
Experimental — accuracy not yet measuredBiosynthesis of ApoB LNPs requires the activity of the microsomal triglyceride transfer protein (MTTP).
“Biosynthesis of ApoB LNPs requires the activity of the microsomal triglyceride transfer protein (MTTP). 41”
From ApoE is Secreted as a Lipid Nanoparticle by Mammalian Cells: Implications for Alzheimer’s Disease Pathogenesis (2025) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Very-low-density lipoprotein assembly and secretion
Shelness, G. S., & Sellers, J. A. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200104000-00008 · Cited by 309 · see citing works
Flagged first, then by citations
Research works printed but not linked: 5
- Havel, R. J., and J. P. Kane. 1995. Introduction: Structure and me- tabolism of plasma lipoproteins. In The Metabolic and Molecular Bases of Inherited Disorders. C. R. Scriver, A. L. Beaudet, W. S. Sly, D. Valle, editors. McGraw-Hill, Inc., New York. 1841-1851.
- Kane, J. P., and R. J. Havel. 1995. Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins. In The Metabolic and Molecular Bases of Inherited Disorders. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill, Inc., New York. 1853-1885.
- Yang, C. Y., T. W. Kim, S. A. Weng, B. R. Lee, M. L. Yang, and A. M. Gotto, Jr. 1990. Isolation and characterization of sulfhydryl and disulfide peptides of human apolipoprotein B-100. Proc. Natl. Acad. Sci. USA. 87: 5523-5527.
- Gordon, D. A., H. Jamil, D. Sharp, D. Mullaney, Z. Yao, R. E. Gregg, and J. Wetterau. 1994. Secretion of apolipoprotein B-con- taining lipoproteins from HeLa cells is dependent on expression of the microsomal triglyceride transfer protein and is regulated by lipid availability. Proc. Natl. Acad. Sci. USA. 91: 7628-7632.
- Jamil,H., D. A. Gordon, D. C. Eustice, C. M. Brooks, J. K. Dickson, Jr., Y. Chen, B. Ricci, C-H. Chu, T. W. Harrity, C. P. Ciosek, Jr., S. A. Biller, R. E. Gregg, and J. R. Wetterau. 1996. An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells. Proc. Natl. Acad. Sci. USA. 93: 11991-11995.
Cited by
Sorted by citations
Lipids and Lipid-Based Formulations: Optimizing the Oral Delivery of Lipophilic Drugs
Porter, C. J. H., Trevaskis, N. L., & Charman, W. N. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2197 · Cited by 1,824 · see citing works
Iqbal, J., & Hussain, M. M. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90899.2008 · Cited by 811 · see citing works
Self-citationHepatokines: Linking nonalcoholic fatty liver disease and insulin resistance
Meex, R. C. R., & Watt, M. J. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.56 · Cited by 631 · see citing works
Lipid-Based Delivery Systems and Intestinal Lymphatic Drug Transport: A Mechanistic Update
Trevaskis, N. L., Charman, W. N., & Porter, C. J. H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.007 · Cited by 442 · see citing works
Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance
Choi, S. H., & Ginsberg, H. N. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.04.007 · Cited by 418 · see citing works
Contois, J. H., McConnell, J. P., Sethi, A. A., Csako, G., Devaraj, S., Hoefner, D. M., & Warnick, G. R. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.118356 · Cited by 326 · see citing works
Lipid disorders and mutations in the APOB gene
Whitfield, A. J., Barrett, P. H. R., van Bockxmeer, F. M., & Burnett, J. R. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.038026 · Cited by 243 · see citing works
FoxO1 integrates insulin signaling to VLDL production.
Kamagate, A., & Dong, H. H. (2008) · Cell Cycle · doi:10.4161/cc.7.20.6882 · Cited by 127 · see citing works
Melanocortin antagonism ameliorates muscle wasting and inflammation in chronic kidney disease
Cheung, W. W., & Mak, R. H. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00341.2012 · Cited by 47 · see citing works
Hernandez Arriaza, R., Reil, D., Fatuzzo, N., Fu, M., Dai, Y., Fernandez Martinez, D., Jiang, H., Holtzman, D. M., Greicius, M. D., & Khosla, C. (2025) · Biochemistry · doi:10.1021/acs.biochem.5c00503 · Cited by 2 · see citing works
- Authors
- Hussain, M. M., Shi, J., & Dreizen, P.
- Affiliations
- SUNY Downstate Health Sciences University (US)
- Corresponding author
- Hussain, M.Mahmood
- ORCID
- Hussain, M.Mahmood
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2003-01
- Volume
- 44
- Issue
- 1
- Pages
- 22-32
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2151400756
- Cited by
- 591
- References
- 1
- Citations by year
- 2026: 30 · 2025: 32 · 2024: 22 · 2023: 12 · 2022: 30 · 2021: 20 · 2020: 25 · 2019: 22 · 2018: 17 · 2017: 19 · 2016: 31 · 2015: 34 · 2014: 28 · 2013: 32 · 2012: 33
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Heart, Lung, and Blood Institute (HL22633, P01HL022633)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-46900)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- microsomal triglyceride transfer protein, apolipoprotein B, lipoprotein assembly, lipid transfer, protein-protein interaction, lipid modification, endoplasmic reticulum, structural motifs
- MeSH terms
- Animals, Apolipoproteins B, Carrier Proteins, Humans, Protein Binding, Structure-Activity Relationship, Protein Structure, Tertiary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review